The market is suffering from a 'three-body problem,' says BTIG's Jonathan Krinsky
Jonathan Krinsky, chief market technician at BTIG, joins CNBC's 'The Exchange to discuss his outlook on stocks for 2025, what ...
BTIG Sticks to Their Buy Rating for Globus Medical (GMED)
In a report released today, Ryan Zimmerman from BTIG reiterated a Buy rating on Globus Medical (GMED – Research Report), with a price target of ...
bovnews1h
What’s Causing Vuzix Corp (VUZI) Stock’s 214.13% Jump Over the Last Six Months?
Vuzix Corp (VUZI) stock saw a modest uptick, ending the day at $4.22 which represents a slight increase of $0.11 or 2.68% from the prior close of $4.11. The stock opened at $4.08 and touched a low of ...
24/7 Wall St. on MSN2d
Large-Cap Value Stocks Could Rule in 2025: 4 High-Yield Dividend Winners
Here are four large-cap value stocks that growth and income investors may want to consider now. History suggests they will ...
GeneDx management to meet with BTIG
BTIG Life Sciences and Diagnostic Tools Analyst Massaro holds group dinner meeting with CEO Stueland and CFO Feeley on January 13 at 10:30 am.
bovnews1h
What’s Fueling Howmet Aerospace Inc (HWM) Stock’s 25.11% Gain Above Its 200-Day SMA?
KeyBanc Capital Markets has recently reduced Howmet Aerospace Inc (HWM) stock to Sector Weight rating, as announced on October 24, 2024, according to Finviz. Earlier, on October 8, 2024, Susquehanna ...
Smart Money Is Betting Big In Bloom Energy Options
In terms of liquidity and interest, the mean open interest for Bloom Energy options trades today is 1697.67 with a total ...
Stock rally faces resistance: BTIG's Krinsky
The S&P 500's rally of 1.8% over just the last two sessions is nice, "but not a game changer yet," according to BTIG's technical guru, Jonathan Krinsky. The chart he provides, below, shows the stock ...
Staar Surgical price target lowered to $39 from $49 at BTIG
BTIG lowered the firm’s price target on Staar Surgical (STAA) to $39 from $49 and keeps a Buy rating on the shares as part of ...
Investing10d
BTIG sees a risk for 'a bigger January decline' in S&P 500
According to a BTIG strategist, the rally in the index was rejected from the previous support trendline and even though there are still four days left for the Santa Claus rally to deliver gains, there ...
Fintel on MSN15h
BTIG Downgrades Palo Alto Networks (PANW)
Fintel reports that on January 8, 2025, BTIG downgraded their outlook for Palo Alto Networks (NasdaqGS:PANW) from Buy to ...
Glaukos price target raised to $157 from $149 at BTIG
BTIG raised the firm’s price target on Glaukos (GKOS) to $157 from $149 and keeps a Buy rating on the shares as part of a broader research note updating the firm’s models on Medical Technology names ...